ASHP to Launch Comprehensive Digital Drug Information Resource
ASHP today announced that it will release a comprehensive suite of its leading drug information databases, including AHFS Drug Information® (AHFS DI), in early 2016. Recruitment for beta testers will begin during ASHP’s 50th Midyear Clinical Meeting this week in New Orleans.
The new product, AHFS® Clinical Drug Information™ (AHFS CDI™), will provide clinicians with easy access to detailed drug information, including real-time drug and safety updates, direct links to more than 60,000 supporting evidence sources, and in-depth coverage of off-label uses.
Users will have access to the full scope of ASHP’s catalog of drug information, including AHFS DI, the nation’s leading compendium of unbiased and authoritative drug information, as well as AHFS Essentials™, which offers quick, point-of-care answers. Also included in the new product are the databases for the Handbook on Injectable Drugs, AHFS Patient Medication Information, and ASHP drug shortages resources prepared in conjunction with the University of Utah Drug Information Service. AHFS CDI will feature additional prescribing information, drug images and imprints, updates on FDA black-box warnings and Risk Evaluation and Mitigation Strategies, and other clinical information.
AHFS drug monographs are thoroughly researched by drug information pharmacists as well as professional editorial and analytical staff. Authors incorporate clinical research findings, guidelines, and FDA-approved labeling into the monographs. A panel of hundreds of reviewers, including leading medical scientists, physicians, pharmacists, pharmacologists, and other clinicians, also examine the materials to ensure accuracy. The print version of AHFS DI is the original compendium designated by the U.S. Congress as a source for reimbursement of off-label uses for medications.
“ASHP’s drug information resources have long been the gold standard for reliable, evidence-based drug information,” said Gerald K. McEvoy, Pharm.D., editor-in-chief of AHFS DI and ASHP assistant vice president of drug information. “We are pleased to be able to expand the availability of these trusted ASHP resources.”
AHFS Clinical Drug Information will be available via Web browser as well as iOS and Android apps. Individual pricing will begin at $10 per month. The user interface will also integrate into clinical workflow solutions in hospitals and ambulatory care settings. Institutional subscription pricing will be provided on request.
ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s more than 40,000 members include pharmacists, student pharmacists, and pharmacy technicians. For over 70 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP’s website, www.ashp.org, or its consumer website, www.SafeMedication.com.